Therapeutic Vaccines Market to Grow at a Double Digit CAGR through 2025
Increasing presence of chronic
diseases such as HIV, alzheimer, cancer, among others to drive global therapeutic
vaccines market
According to TechSci Research report, “Global
Therapeutic
Vaccines Market
By Type (Antigen Vaccine, Dendritic Cell Vaccine, DNA Vaccines, Tumor cell
vaccine), By Product (Addiction Vaccines, Auto Immune Disease Vaccines,
Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccine,
Others), By Technology (Autologous Vaccines, Allogeneic Vaccines), By Delivery
Mechanism (Nasal, Electroporation), By End User (Private Hospitals, Government Hospitals, Specialty Clinics), By Region, Forecast &
Opportunities, 2025”, the
global therapeutic vaccines market is expected
to grow at a double digit CAGR during the forecast period on account of
increasing cases of chronic diseases and increasing demand for therapeutic vaccines
as they help to boost the immune system. Over the years, they have become quite
popular in the market due to the increasing awareness in the population about
protection from chronic and harmful diseases. Even though the cost of provision
of therapeutic vaccines is high, the government has started investing in this
market in order to keep the population disease-free. The distinctness and
uniqueness of therapeutic vaccines makes them hard to manufacture for every
different disease, thus it can be said that it is a demand-based market, which
is quite a factor that can hinder the growth of the market as the absence of
demand takes down the supply as well, consequently hampering the market.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on"Global
Therapeutic Vaccines Market"
https://www.techsciresearch.com/report/therapeutic-vaccines-market/4606.html
Global therapeutic vaccines market is segmented based
on type, product, technology, delivery mechanism, end user, company and region.
In terms of product, market is segmented into addiction vaccines, auto immune
disease vaccines, neurological disease vaccines, cancer vaccines, infectious
disease vaccine and others. Amongst the above-mentioned product types, auto
immune disease vaccine segment is expected to dominate the market as autoimmune
diseases are amongst the top ten major causes of death among people across the
globe. These diseases attack the healthy tissues in a body and can lead to
organ disfunction, cancer, tumor, etc.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4606
Customers can also request for 10% free customization on
this report.
The leading players in the global therapeutic vaccine
market include Sanofi Pasteur SA de CV, Intellect Neurosciences Inc, Agenus Inc,
Celtic Pharma Holdings Advisors LLC, Novartis AG, Bavarian Nordic A/S, Transgene SA, Argos
Therapeutics Inc, Celldex Therapeutics Inc, CureVac GmbH, etc. In order to expand their
market share, the companies adopt various strategies like new product launches,
collaborations.
“In terms of regional analysis, North America accounted
for the largest share in the global therapeutic vaccines market on account of
technological advancements, advanced healthcare systems and large auto-immune
disease patient base in the region. Moreover, presence of favorable regulations
and introduction of Affordable Care Act, is anticipated to positively influence
the growth of the market until 2025.” said Mr. Karan Chechi, Research Director
with TechSci Research, a research based global management consulting firm.
“Global
Therapeutic Vaccines Market By Type (Antigen
Vaccine, Dendritic Cell Vaccine,
DNA Vaccines, Tumor cell vaccine), By Product (Addiction Vaccines, Auto Immune
Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious
Disease Vaccine, Others), By Technology (Autologous Vaccines, Allogeneic
Vaccines), By Delivery Mechanism (Nasal, Electroporation), By End User (Private Hospitals, Government Hospitals, Specialty
Clinics),
By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global therapeutic
vaccines market and provided statistics & information on market size, shares,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global therapeutic vaccines market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]